Literature DB >> 9377916

Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia.

J Baraibar1, H Correa, D Mariscal, M Gallego, J Vallés, J Rello.   

Abstract

STUDY
OBJECTIVE: To investigate the epidemiology of infection by Acinetobacter baumannii in patients with ventilator-associated pneumonia (VAP).
DESIGN: Prospective clinical study.
SETTING: Three medical-surgical ICUs in teaching hospitals. PATIENTS: We followed up 707 mechanically ventilated patients and 148 episodes of VAP with etiologic diagnosis.
RESULTS: A baumannii was isolated in 12 (8.1%) episodes in 148 patients. Five of these episodes were directly responsible for death. Using logistic regression analysis, the risk of VAP due to A baumannii was found to be high in patients with neurosurgery (odds ratio [OR]=10.03; 95% confidence interval [CI]=1.55 to 64.90), ARDS (OR=9.73; 95% CI=1.60 to 59.24), head trauma (OR=5.17; 95% CI=0.88 to 30.34), and large-volume pulmonary aspiration (OR=2.90; 95% CI=0.80 to 10.53).
CONCLUSIONS: Intubated patients who develop pneumonia and have any of the above factors are at an increased risk of Acinetobacter infection.

Entities:  

Mesh:

Year:  1997        PMID: 9377916     DOI: 10.1378/chest.112.4.1050

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  24 in total

1.  Acinetobacter baumannii: a threat for the ICU?

Authors:  Jordi Rello; Emili Diaz
Journal:  Intensive Care Med       Date:  2003-02-13       Impact factor: 17.440

Review 2.  Acinetobacter pneumonia: a review.

Authors:  Joshua D Hartzell; Andrew S Kim; Mark G Kortepeter; Kimberly A Moran
Journal:  MedGenMed       Date:  2007-07-05

Review 3.  Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy".

Authors:  Alberto Sandiumenge; Emili Diaz; Maria Bodí; Jordi Rello
Journal:  Intensive Care Med       Date:  2003-04-02       Impact factor: 17.440

4.  Epidemiology of ventilator-associated tracheobronchitis and vantilator-associated pneumonia in patients with inhalation injury at the Burn Centre in Brno (Czech Republic).

Authors:  B Lipovy; H Rihová; N Gregorova; M Hanslianova; Z Zaloudikova; Y Kaloudova; P Brychta
Journal:  Ann Burns Fire Disasters       Date:  2011-09-30

5.  Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings.

Authors:  José Garnacho-Montero; C Ortiz-Leyba; Esteban Fernández-Hinojosa; Teresa Aldabó-Pallás; Aurelio Cayuela; Juan A Marquez-Vácaro; Andrés Garcia-Curiel; F J Jiménez-Jiménez
Journal:  Intensive Care Med       Date:  2005-03-23       Impact factor: 17.440

6.  Acinetobacter pneumonia: Is the outcome different from the pneumonias caused by other agents.

Authors:  Ebru Cakir Edis; Osman N Hatipoglu; Ozlem Tansel; Necdet Sut
Journal:  Ann Thorac Med       Date:  2010-04       Impact factor: 2.219

7.  Acinetobacter baumannii infections in a surgical intensive care unit: predictors of multi-drug resistance.

Authors:  Stilianos Katsaragakis; Haridimos Markogiannakis; Konstantinos G Toutouzas; Panagiotis Drimousis; Andreas Larentzakis; Eleni-Maria Theodoraki; Dimitrios Theodorou
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

8.  Comparison of risk factors for recovery of Acinetobacter baumannii during outbreaks at two Kentucky hospitals, 2006.

Authors:  Suzanne F Beavers; David B Blossom; Timothy L Wiemken; Kelly Y Kawaoka; Andrew Wong; Linda Goss; Malkanthie I McCormick; Douglas Thoroughman; Arjun Srinivasan
Journal:  Public Health Rep       Date:  2009 Nov-Dec       Impact factor: 2.792

9.  Management of ventilator-associated pneumonia in a multidisciplinary intensive care unit: does trauma make a difference?

Authors:  Kemal Agbaht; Thiago Lisboa; Angel Pobo; Alejandro Rodriguez; Alberto Sandiumenge; Emili Diaz; Jordi Rello
Journal:  Intensive Care Med       Date:  2007-06-12       Impact factor: 17.440

10.  Risk factors and outcome of Acinetobacter baumanii infection in severe trauma patients.

Authors:  Anselmo Caricato; Luca Montini; Giuseppe Bello; Vincenzo Michetti; Riccardo Maviglia; Maria G Bocci; Giovanna Mercurio; Salvatore M Maggiore; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2009-08-04       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.